DOCSLIB.ORG

Genomic Actions of Estrogen Receptor A: What Are the Targets and How Are They Regulated?

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Genomic Actions of Estrogen Receptor A: What Are the Targets and How Are They Regulated? Endocrine-Related Cancer (2009) 16 1073–1089 REVIEW Genomic actions of estrogen receptor a: what are the targets and how are they regulated? Willem-Jan Welboren, Fred C G J Sweep1, Paul N Span1,2 and Hendrik G Stunnenberg Department of Molecular Biology, Faculty of Science, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen, PO Box 9101, HB Nijmegen, The Netherlands Departments of 1Chemical Endocrinology and 2Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands (Correspondence should be addressed to H G Stunnenberg; Email: [email protected]) Abstract The estrogen receptor a (ERa) is a ligand-dependent transcription factor that regulates a large number of genes in many different target tissues and is important in the development and progression of breast cancer. ERa-mediated transcription is a complex process regulated at many different levels. The interplay between ligand, receptor, DNA sequence, cofactors, chromatin context, and post-translational modifications culminates in transcriptional regulation by ERa. Recent technological advances have allowed the identification of ERa target genes on a genome- wide scale. In this review, we provide an overview of the progress made in our understanding of the different levels of regulation mediated by ERa. We discuss the recent advances in the identification of the ERa-binding sites and target gene network and their clinical applications. Endocrine-Related Cancer (2009) 16 1073–1089 Introduction thereby making the link between cancer and estrogens that was described almost a century before (Jensen Estrogens regulate many cellular processes in a wide et al. 1971, McGuire 1973). The subsequent cloning of variety of target tissues during growth, development, the ERa gene and the identification of specific domains and differentiation. Estrogens are mainly involved in demonstrated that ERa functions as a ligand-dependent the regulation and development of the female transcription factor (Green et al.1986, Greene et al. reproductive tract but also play a role in the central 1986, Kumar et al. 1987). The structures of ERa and its nervous system, cardiovascular systems, and in bone nongenomic regulation have been reviewed exten- metabolism (Katzenellenbogen 1996). In addition to sively (Ruff et al. 2000, Warner & Gustafsson 2006). their role in physiology, estrogens are also associated This review will focus on the regulation of ERa- with the development and progression of breast cancer mediated transcription and on the advances made in the (Anderson 2002). In 1896, Beatson discovered that elucidation of its target gene network. Furthermore, the removal of the ovaries resulted in breast cancer clinical significance and implications of ERa remission, connecting for the first time hormones expression and genome-wide chromatin immuno- with breast cancer, decades prior to the discovery of precipitation (ChIP) profiling is discussed. estrogens or estrogen receptors (ERs). Seventy years later, O’Malley observed changes in hybridizable RNA upon estrogen stimulation of the chick oviduct, Estrogen receptor indicating that estrogens regulate transcription The ERa (NR3A1) is a member of the super family of (O’Malley et al. 1968). Again several years later a nuclear receptors, which are ligand-dependent tran- specific estrogen-binding protein was discovered that scription factors. In addition to ERa, the family was present in breast tumors and its expression level includes other steroid hormone receptors such as the could predict the response to endocrine disruption, androgen receptor (AR, NR3C4), the glucocorticoid Endocrine-Related Cancer (2009) 16 1073–1089 Downloaded from Bioscientifica.comDOI: 10.1677/ERC-09-0086 at 09/27/2021 07:17:52AM 1351–0088/09/016–001073 q 2009 Society for Endocrinology Printed in Great Britain Online version via http://www.endocrinology-journals.orgvia free access W-J Welboren et al.: Genomic actions of estrogen receptor a receptor (GR, NR3C1), and other nuclear receptors to kB elements and regulates the expression of target such as the retinoic acid receptor (RAR, NR1B), genes. ERa has been shown to inhibit NF-kBinan retinoid X receptor (RXR, NR2B), and peroxisome E2-dependent manner. The ERa can directly inhibit the proliferators-activated receptor (PPAR, NR1C). Estro- binding of NF-kB transcription factors to the DNA, but gens are small lipophilic molecules that traverse the the mechanism is poorly understood. cell membrane and bind to cytoplasmic ERa associated with chaperone proteins such as hsp90. Upon binding a cascade of events occur; the receptor dissociates from Target gene network the chaperone proteins, dimerizes and associates with Single gene analysis chromatin. ERa can either bind directly to DNA To fully elucidate ERa function, the identification of (classical pathway) or indirectly via protein–protein its target gene network is essential. Many strategies interactions (nonclassical pathway). In the classical have been employed to gain insights into the target pathway, ERa homodimers bind to a specific DNA gene network governed by the ERa. Classically, target sequence motif, the estrogen response element (ERE). genes have been identified using ‘single gene’ The ERE is a 15 bp palindrome consisting of two experiments. The egg-white proteins in the chicken PuGGTCA half sites separated by a 3 bp spacer. ERa is oviduct and the Xenopus laevis vitellogenin gene are also able to bind to imperfect EREs. Recent genome- among the first ERa target genes to be identified wide studies show that the ERE is the most (Hayward et al. 1982, Lai et al. 1983, Chambon et al. predominant motif in ERa-binding sites (Carroll 1984, Jost et al.1984). Later, by comparing cDNA et al. 2006, Lin et al. 2007, Welboren et al. 2009). libraries of nontreated and E -treated MCF-7 human In the nonclassical pathway, the ERa binds indirectly 2 breast cancer cells several other ERa-responsive genes to the DNA via tethering to other transcription factors were identified such as the classical and intensively such as specificity protein 1 (Sp1), activating protein 1 studied ERa target gene pS2/TFF1 (Brown et al. 1984, (AP-1), or nuclear factor kappa b (NF-kB), and Jakowlew et al. 1984). ERa-regulated genes identified regulates transcription in an ERE-independent manner. using differential cloning are e.g. the cell cycle The Sp1 family of transcriptional factors plays an regulators c-myc and cyclin D1, connecting prolifera- important role in proliferation, differentiation, survival, tion with E signaling (Dubik et al. 1987, Altucci and angiogenesis (Kaczynski et al. 2003, Safe & 2 et al. 1996). Abdelrahim 2005). Sp1 can bind to GC-rich regions, which are present in many estradiol (E2) responsive promoters. For example, mutational analysis revealed Estrogen response elements that the GC-rich region in the promoter of the The first ERE was identified in 1986 in the promoter of transforming growth factor a (TGFa) gene is required the Xenopus vitellogenin gene. Transfection experi- for E2-mediated gene activation (Vyhlidal et al. 2000). ments showed that this element also functions in Several other genes have been identified that are human cells, and that the core ERE could be defined activated by the ER/Sp1 pathway including e.g. the as a 13 bp palindrome (GGTCANNNTGACC; c-myc and progesterone receptor genes (Miller et al. Klein-Hitpass et al. 1986). The availability of the 1996, Petz & Nardulli 2000). The transcription factor entire human genome sequence allowed the compu- AP-1 is a complex containing fos, jun, and other family tational search for EREs and ERa target genes. This members. Several E2-regulated genes are dependent on approach led to the interesting observation that AP-1, such as insulin-like growth factor I (IGF-I), w70 000 EREs are present in the human genome, i.e. ovalbumin, progesterone receptor, and pS2/TFF1 one in every 43 kb of DNA (Bourdeau et al. 2004). By (Gaub et al. 1990, Savouret et al. 1994, Umayahara comparing these with the merely 9944 EREs identified et al. 1994, Barkhem et al.2002). The AP-1 complex in the mouse genome, a total of 660 evolutionary binds to promoters of genes involved in growth, conserved elements were found. The large number of differentiation, and development. Many ER/AP-1- EREs present in the genome and limited conservation responsive genes have been identified using microarray between human and mouse indicates that a large studies, indicating that E2-mediated regulation via the fraction of the EREs may not be ‘true’ ERa-binding nonclassical pathway occurs frequently (DeNardo sites. These in silico studies suggested that actual et al. 2005, Glidewell-Kenney et al.2005). The binding by ERa is dependent on more factors than just NF-kB family of transcriptional factors are involved the DNA sequence. The hypothesis was put forward in the immune and skeletal systems and inflammatory that the chromatin structure and hence the accessibility response (Kalaitzidis & Gilmore 2005). NF-kB binds of binding sites plays a major role. Furthermore, the Downloaded from Bioscientifica.com at 09/27/2021 07:17:52AM via free access 1074 www.endocrinology-journals.org Endocrine-Related Cancer (2009) 16 1073–1089 notion that sequence is not the only or decisive in karyotype, hormone receptor content, and growth determinant in ERa binding is underscored by the rate have been observed although morphologically the observation that ERa can bind indirectly via tethering cells look(ed) identical (Osborne et al. 1987, Bahia to other transcription factors and subsequently regulate et al. 2002, Burdall et al. 2003). target genes in an ERE-independent manner. It is important to note that a disadvantage of expression profiling is that indirect effects that affect the mRNA level are also measured which could be a Expression profiling major source of the observed differences. Lin et al. Microarrays, either cDNA or oligonucleotide, and used the translation inhibitor cyclohexamide combined serial analysis of gene expression are powerful tools with the ERa antagonist ICI 182,780 to show that only that can be used to assess global changes in gene a relatively small number (23%) of E2-responsive expression.
Load more

Recommended publications
  • Enhancer Priming by H3K4 Methylation Safeguards Germline Competence
    bioRxiv preprint doi: https://doi.org/10.1101/2020.07.07.192427; this version posted July 7, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Title: Enhancer priming by H3K4 methylation safeguards germline competence 1* 1 1,2 Authors: Tore Bleckwehl ​ ,​ Kaitlin Schaaf ,​ Giuliano Crispatzu ,​ Patricia ​ ​ ​ ​ 1,3 1,4 5 5 Respuela ,​ Michaela Bartusel ,​ Laura Benson ,​ Stephen J. Clark ,​ Kristel M. ​ ​ ​ ​ 6 7 1,8 7,9 Dorighi ,​ Antonio Barral ,​ Magdalena Laugsch ,​ Miguel Manzanares ,​ Joanna ​ ​ ​ ​ 6,10,11 5,12,13 1,3,14* Wysocka ,​ Wolf Reik ,​ Álvaro Rada-Iglesias ​ ​ ​ ​ ​ ​ Affiliations: 1 Center for Molecular Medicine Cologne (CMMC), University of Cologne, Germany. 2 Department of Internal Medicine 2, University Hospital Cologne. 3 Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC), CSIC/University of Cantabria, Spain. 4 Department of Biology, Massachusetts Institute of Technology, USA. 5 Epigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK. 6 Department of Chemical and Systems Biology, Stanford University School of Medicine, USA. 7 Centro Nacional de Investigaciones Cardiovasculares (CNIC), Spain. 8 Institute of Human Genetics, Heidelberg University Hospital, Germany. 9 Centro de Biología Molecular Severo Ochoa (CBMSO), CSIC-UAM, Spain. 10 Department of Developmental Biology, Stanford University School of Medicine, USA. 11 Howard Hughes Medical Institute, Stanford University School of Medicine, USA. 12 Centre for Trophoblast Research, University of Cambridge, CB2 3EG, UK 13 Wellcome Trust Sanger Institute, Cambridge CB10 1SA, UK.
    [Show full text]
  • Dimethylation of Histone 3 Lysine 9 Is Sensitive to the Epileptic Activity
    1368 MOLECULAR MEDICINE REPORTS 17: 1368-1374, 2018 Dimethylation of Histone 3 Lysine 9 is sensitive to the epileptic activity, and affects the transcriptional regulation of the potassium channel Kcnj10 gene in epileptic rats SHAO-PING ZHANG1,2*, MAN ZHANG1*, HONG TAO1, YAN LUO1, TAO HE3, CHUN-HUI WANG3, XIAO-CHENG LI3, LING CHEN1,3, LIN-NA ZHANG1, TAO SUN2 and QI-KUAN HU1-3 1Department of Physiology; 2Ningxia Key Laboratory of Cerebrocranial Diseases, Incubation Base of National Key Laboratory, Ningxia Medical University; 3General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China Received February 18, 2017; Accepted September 13, 2017 DOI: 10.3892/mmr.2017.7942 Abstract. Potassium channels can be affected by epileptic G9a by 2-(Hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6,7-di- seizures and serve a crucial role in the pathophysiology of methoxy-N-(1-(phenyl-methyl)-4-piperidinyl)-4-quinazolinamine epilepsy. Dimethylation of histone 3 lysine 9 (H3K9me2) and tri-hydrochloride hydrate (bix01294) resulted in upregulation its enzyme euchromatic histone-lysine N-methyltransferase 2 of the expression of Kir4.1 proteins. The present study demon- (G9a) are the major epigenetic modulators and are associated strated that H3K9me2 and G9a are sensitive to epileptic seizure with gene silencing. Insight into whether H3K9me2 and G9a activity during the acute phase of epilepsy and can affect the can respond to epileptic seizures and regulate expression of transcriptional regulation of the Kcnj10 channel. genes encoding potassium channels is the main purpose of the present study. A total of 16 subtypes of potassium channel Introduction genes in pilocarpine-modelled epileptic rats were screened by reverse transcription-quantitative polymerase chain reac- Epilepsies are disorders of neuronal excitability, characterized tion, and it was determined that the expression ATP-sensitive by spontaneous and recurrent seizures.
    [Show full text]
  • Identification and Characterization of Posttranslational Modification-Specific Binding Proteins in Vivo by Mammalian Tethered Catalysis
    Identification and characterization of posttranslational modification-specific binding proteins in vivo by mammalian tethered catalysis Tanya M. Spektor and Judd C. Rice1 Department of Biochemistry and Molecular Biology, University of Southern California Keck School of Medicine, Los Angeles, CA 90033 Communicated by C. David Allis, The Rockefeller University, New York, NY, July 14, 2009 (received for review February 26, 2009) Increasing evidence indicates that an important consequence of To overcome some of the limitations of in vitro approaches, a protein posttranslational modification (PTM) is the creation of a high previously undescribed in vivo method called yeast tethered catal- affinity binding site for the selective interaction with a PTM-specific ysis was developed (1). Briefly, an expressed fusion protein con- binding protein (BP). This PTM-mediated interaction is typically re- taining a target peptide sequence was tethered to an enzyme quired for downstream signaling propagation and corresponding resulting in the constitutive PTM of the peptide and, thereby, biological responses. Because the vast majority of mammalian pro- served as the bait in yeast two-hybrid screens for putative PTMBPs. teins contain PTMs, there is an immediate need to discover and Although this technique was used successfully to identify yeast characterize previously undescribed PTMBPs. To this end, we devel- PTMBPs, the ability to detect PTMBPs in higher eukaryotes is oped and validated an innovative in vivo approach called mammalian constrained by the limitations
    [Show full text]
  • Caenorhabditis Elegans Deficient in DOT-1.1 Exhibit Increases in H3k9me2 at Enhancer and Certain Rnai-Regulated Regions
    cells Article Caenorhabditis elegans Deficient in DOT-1.1 Exhibit Increases in H3K9me2 at Enhancer and Certain RNAi-Regulated Regions Ruben Esse y and Alla Grishok * Department of Biochemistry, BU Genome Science Institute, Boston University School of Medicine, Boston, MA 02118, USA; [email protected] * Correspondence: [email protected] Present address: Department of Medical and Molecular Genetics, King’s College London, y London SE1 9RT, UK. Received: 15 May 2020; Accepted: 29 July 2020; Published: 6 August 2020 Abstract: The methylation of histone H3 at lysine 79 is a feature of open chromatin. It is deposited by the conserved histone methyltransferase DOT1. Recently, DOT1 localization and H3K79 methylation (H3K79me) have been correlated with enhancers in C. elegans and mammalian cells. Since earlier research implicated H3K79me in preventing heterochromatin formation both in yeast and leukemic cells, we sought to inquire whether a H3K79me deficiency would lead to higher levels of heterochromatic histone modifications, specifically H3K9me2, at developmental enhancers in C. elegans. Therefore, we used H3K9me2 ChIP-seq to compare its abundance in control and dot-1.1 loss-of-function mutant worms, as well as in rde-4; dot-1.1 and rde-1; dot-1.1 double mutants. The rde-1 and rde-4 genes are components of the RNAi pathway in C. elegans, and RNAi is known to initiate H3K9 methylation in many organisms, including C. elegans. We have previously shown that dot-1.1( ) − lethality is rescued by rde-1 and rde-4 loss-of-function. Here we found that H3K9me2 was elevated in enhancer, but not promoter, regions bound by the DOT-1.1/ZFP-1 complex in dot-1.1( ) worms.
    [Show full text]
  • G9a Selectively Represses a Class of Late-Replicating Genes at the Nuclear Periphery
    G9a selectively represses a class of late-replicating genes at the nuclear periphery Tomoki Yokochia,1, Kristina Poducha, Tyrone Rybaa, Junjie Lua, Ichiro Hiratania, Makoto Tachibanab, Yoichi Shinkaib, and David M. Gilberta,2 aDepartment of Biological Science, Florida State University, Tallahassee, FL 32306; and bExperimental Research Center for Infectious Diseases, Institute for Virus Research, Kyoto University, Kyoto 606-8507, Japan Edited by Mark T. Groudine, Fred Hutchinson Cancer Research Center, Seattle, WA, and approved September 25, 2009 (received for review June 4, 2009) We have investigated the role of the histone methyltransferase G9a ery and that G9a-null ESCs are selectively depleted of the in the establishment of silent nuclear compartments. Following con- H3K9me2 localized at the periphery (13). Chromatin at the nuclear ditional knockout of the G9a methyltransferase in mouse ESCs, 167 periphery also is replicated late during S-phase, and differentiation genes were significantly up-regulated, and no genes were strongly of ESCs leads to changes in the replication timing of large chro- down-regulated. A partially overlapping set of 119 genes were matin domains, accompanied by the movement of those domains up-regulated after differentiation of G9a-depleted cells to neural toward or away from the nuclear periphery and the respective precursors. Promoters of these G9a-repressed genes were AT rich and silencing or activation of genes within those domains (14). To- H3K9me2 enriched but H3K4me3 depleted and were not highly DNA gether, these results suggested the possibility that G9a may help methylated. Representative genes were found to be close to the establish compartments of facultative heterochromatin at the nu- nuclear periphery, which was significantly enriched for G9a-depen- clear periphery.
    [Show full text]
  • Catalytic Inhibition of H3k9me2 Writers Disturbs Epigenetic Marks
    www.nature.com/scientificreports OPEN Catalytic inhibition of H3K9me2 writers disturbs epigenetic marks during bovine nuclear reprogramming Rafael Vilar Sampaio 1,3,4*, Juliano Rodrigues Sangalli1,4, Tiago Henrique Camara De Bem 1, Dewison Ricardo Ambrizi1, Maite del Collado 1, Alessandra Bridi 1, Ana Clara Faquineli Cavalcante Mendes de Ávila1, Carolina Habermann Macabelli 2, Lilian de Jesus Oliveira1, Juliano Coelho da Silveira 1, Marcos Roberto Chiaratti 2, Felipe Perecin 1, Fabiana Fernandes Bressan1, Lawrence Charles Smith3, Pablo J Ross 4 & Flávio Vieira Meirelles1* Orchestrated events, including extensive changes in epigenetic marks, allow a somatic nucleus to become totipotent after transfer into an oocyte, a process termed nuclear reprogramming. Recently, several strategies have been applied in order to improve reprogramming efciency, mainly focused on removing repressive epigenetic marks such as histone methylation from the somatic nucleus. Herein we used the specifc and non-toxic chemical probe UNC0638 to inhibit the catalytic activity of the histone methyltransferases EHMT1 and EHMT2. Either the donor cell (before reconstruction) or the early embryo was exposed to the probe to assess its efect on developmental rates and epigenetic marks. First, we showed that the treatment of bovine fbroblasts with UNC0638 did mitigate the levels of H3K9me2. Moreover, H3K9me2 levels were decreased in cloned embryos regardless of treating either donor cells or early embryos with UNC0638. Additional epigenetic marks such as H3K9me3, 5mC, and 5hmC were also afected by the UNC0638 treatment. Therefore, the use of UNC0638 did diminish the levels of H3K9me2 and H3K9me3 in SCNT-derived blastocysts, but this was unable to improve their preimplantation development.
    [Show full text]
  • Abo1 Is Required for the H3k9me2 to H3k9me3 Transition in Heterochromatin Wenbo Dong1, Eriko Oya1, Yasaman Zahedi1, Punit Prasad 1,2, J
    www.nature.com/scientificreports OPEN Abo1 is required for the H3K9me2 to H3K9me3 transition in heterochromatin Wenbo Dong1, Eriko Oya1, Yasaman Zahedi1, Punit Prasad 1,2, J. Peter Svensson 1, Andreas Lennartsson1, Karl Ekwall1 & Mickaël Durand-Dubief 1* Heterochromatin regulation is critical for genomic stability. Diferent H3K9 methylation states have been discovered, with distinct roles in heterochromatin formation and silencing. However, how the transition from H3K9me2 to H3K9me3 is controlled is still unclear. Here, we investigate the role of the conserved bromodomain AAA-ATPase, Abo1, involved in maintaining global nucleosome organisation in fssion yeast. We identifed several key factors involved in heterochromatin silencing that interact genetically with Abo1: histone deacetylase Clr3, H3K9 methyltransferase Clr4, and HP1 homolog Swi6. Cells lacking Abo1 cultivated at 30 °C exhibit an imbalance of H3K9me2 and H3K9me3 in heterochromatin. In abo1∆ cells, the centromeric constitutive heterochromatin has increased H3K9me2 but decreased H3K9me3 levels compared to wild-type. In contrast, facultative heterochromatin regions exhibit reduced H3K9me2 and H3K9me3 levels in abo1∆. Genome-wide analysis showed that abo1∆ cells have silencing defects in both the centromeres and subtelomeres, but not in a subset of heterochromatin islands in our condition. Thus, our work uncovers a role of Abo1 in stabilising directly or indirectly Clr4 recruitment to allow the H3K9me2 to H3K9me3 transition in heterochromatin. In eukaryotic cells, the regions of the chromatin that contain active genes are termed euchromatin, and these regions condense in mitosis to allow for chromosome segregation and decondense in interphase to allow for gene transcription1. Te chromatin regions that remain condensed throughout the cell cycle are defned as het- erochromatin regions and are transcriptionally repressed2,3.
    [Show full text]
  • Catalytic Inhibition of H3k9me2 Writers Disturbs Epigenetic Marks During Bovine Nuclear
    bioRxiv preprint doi: https://doi.org/10.1101/847210; this version posted November 20, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 1 Catalytic inhibition of H3K9me2 writers disturbs epigenetic marks during bovine nuclear 2 reprogramming. 3 1,3,4Sampaio RV*, 1,4Sangalli JR, 1De Bem THC, 1Ambrizi DR, 1 del Collado M, 1 Bridi A, 1 Ávila 4 ACFCM, 2Macabelli CH, 1Oliveira LJ, 1da Silveira JC, 2Chiaratti MR, 1Perecin F,1Bressan FF; 5 3Smith LC, 4Ross PJ, 1Meirelles FV. 6 1 Departament of Veterinary Medicine, Faculty of Animal Science and Food Engineering, 7 University of Sao Paulo, Pirassununga, SP, Brazil. 2Departament of Genetic and Evolution, 8 Federal University of São Carlos, São Carlos, SP, Brazil. 3 Université de Montréal, Faculté de 9 médecine vétérinaire, Centre de recherche en reproduction et fertilité, St. Hyacinthe, Québec, 10 postcode: H3T 1J4, Canada.4Department of Animal Science, University of California Davis, 11 USA. 12 *Correspondence 13 Rafael Vilar Sampaio, Department of Veterinary Medicine, Faculty of Food Engineering and 14 Animal Science, University of Sao Paulo, Pirassununga, Sao Paulo, Brazil. Email: 15 [email protected] 16 Abstract 17 Orchestrated events, including extensive changes in epigenetic marks, allow a somatic nucleus to 18 become totipotent after transfer into an oocyte, a process termed nuclear reprogramming. 19 Recently, several strategies have been applied in order to improve reprogramming efficiency, 20 mainly focused on removing repressive epigenetic marks such as histone methylation from the 21 somatic nucleus.
    [Show full text]
  • Cocaine Dynamically Regulates Heterochromatin and Repetitive Element Unsilencing in Nucleus Accumbens
    Cocaine dynamically regulates heterochromatin and repetitive element unsilencing in nucleus accumbens Ian Maze1, Jian Feng, Matthew B. Wilkinson, HaoSheng Sun, Li Shen, and Eric J. Nestler2 Fishberg Department of Neuroscience, Mount Sinai School of Medicine, New York, NY 10029 Edited by Solomon H. Snyder, The Johns Hopkins University School of Medicine, Baltimore, MD, and approved January 7, 2011 (received for review October 14, 2010) Repeated cocaine exposure induces persistent alterations in Although much work in recent years has focused on euchro- genome-wide transcriptional regulatory networks, chromatin re- matic chromatin remodeling in the development of addictive-like modeling activity and, ultimately, gene expression profiles in the behaviors, very little attention has been placed on examining the brain’s reward circuitry. Virtually all previous investigations have potential consequences of repeated drug exposure on hetero- centered on drug-mediated effects occurring throughout active eu- chromatic formation and genomic silencing in adult brain. One chromatic regions of the genome, with very little known concerning of the most heavily characterized markers of heterochromatin is the impact of cocaine exposure on the regulation and maintenance trimethylated lysine 9 on H3 (H3K9me3). H3K9 can exist in a of heterochromatin in adult brain. Here, we report that cocaine mono- (H3K9me1), di- (H3K9me2), or trimethylated state, in dramatically and dynamically alters heterochromatic histone H3 ly- which multiple methyltransferase and demethylase
    [Show full text]
  • H3k9me2 Orchestrates Inheritance of Spatial Positioning of Peripheral Heterochromatin Through Mitosis
    bioRxiv preprint doi: https://doi.org/10.1101/678987; this version posted June 21, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. H3K9me2 orchestrates inheritance of spatial positioning of peripheral heterochromatin through mitosis Andrey Poleshko1, Cheryl L. Smith1, Son C. Nguyen2, Priya Sivaramakrishnan2, John Isaac Murray2, Melike Lakadamyali3, Eric F. Joyce2, Rajan Jain1,4*, and Jonathan A. Epstein1,4* 1Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 2Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 3Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 4Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. *Correspondence: Jonathan Epstein 602 South Tower, PCAM 3400 Civic Center Blvd. Philadelphia, PA 19104 1 (215) 898-8731 [email protected] Rajan Jain Smilow Center for Translational Research 3400 Civic Center Blvd., Room 09-102 Philadelphia, PA 19104 1 (215) 573-3011 [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/678987; this version posted June 21, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Abstract Cell-type-specific 3D organization of the genome is unrecognizable during mitosis.
    [Show full text]
  • The Drosophila Dot Chromosome: Where Genes Flourish Amidst Repeats
    | FLYBOOK GENOME ORGANIZATION The Drosophila Dot Chromosome: Where Genes Flourish Amidst Repeats Nicole C. Riddle*,1 and Sarah C. R. Elgin† *Department of Biology, The University of Alabama at Birmingham, Alabama 35294 and †Department of Biology, Washington University in St. Louis, Missouri 63130 ORCID ID: 0000-0003-1827-9145 (N.C.R.) ABSTRACT The F element of the Drosophila karyotype (the fourth chromosome in Drosophila melanogaster) is often referred to as the “dot chromosome” because of its appearance in a metaphase chromosome spread. This chromosome is distinct from other Drosophila autosomes in possessing both a high level of repetitious sequences (in particular, remnants of transposable elements) and a gene density similar to that found in the other chromosome arms, 80 genes distributed throughout its 1.3-Mb “long arm.” The dot chromosome is notorious for its lack of recombination and is often neglected as a consequence. This and other features suggest that the F element is packaged as heterochromatin throughout. F element genes have distinct characteristics (e.g., low codon bias, and larger size due both to larger introns and an increased number of exons), but exhibit expression levels comparable to genes found in euchromatin. Mapping experiments show the presence of appropriate chromatin modifications for the formation of DNaseI hyper- sensitive sites and transcript initiation at the 59 ends of active genes, but, in most cases, high levels of heterochromatin proteins are observed over the body of these genes. These various features raise many interesting questions about the relationships of chromatin structures with gene and chromosome function. The apparent evolution of the F element as an autosome from an ancestral sex chromosome also raises intriguing questions.
    [Show full text]
  • Spreading and Epigenetic Inheritance of Heterochromatin Require a Critical Density of Histone H3 Lysine 9 Tri-Methylation
    Spreading and epigenetic inheritance of heterochromatin require a critical density of histone H3 lysine 9 tri-methylation Amber R. Cutter DiPiazzaa, Nitika Tanejaa,1, Jothy Dhakshnamoorthya, David Wheelera, Sahana Hollaa, and Shiv I. S. Grewala,2 aLaboratory of Biochemistry and Molecular Biology, National Cancer Institute, NIH, Bethesda, MD 20892 Edited by Steven E. Jacobsen, University of California, Los Angeles, CA, and approved April 20, 2021 (received for review January 12, 2021) Heterochromatin assembly requires methylation of histone H3 domains coat pericentromeric, subtelomeric, and the silent mating- lysine 9 (H3K9me) and serves as a paradigm for understanding the type (mat) regions (9–12). Heterochromatin assembly is a multistep importance of histone modifications in epigenetic genome control. process that includes nucleation and spreading. The de novo nu- Heterochromatin is nucleated at specific genomic sites and spreads cleation of heterochromatin occurs at specific sites, such as repeat across extended chromosomal domains to promote gene silencing. elements within constitutive heterochromatin domains, from where Moreover, heterochromatic structures can be epigenetically inherited heterochromatin factors spread to surrounding sequences (13, 14). in a self-templating manner, which is critical for stable gene repres- RNAi machinery (13, 15), as well as factors involved in nuclear sion. The spreading and inheritance of heterochromatin are believed RNA processing and noncanonical RNA polymerase II termi- to be dependent on preexisting H3K9 tri-methylation (H3K9me3), nation (12, 16–19), nucleate heterochromatin by targeting the which is recognized by the histone methyltransferase Clr4/Suv39h multisubunit Clr4 methyltransferase complex (ClrC) (20) that is via its chromodomain, to promote further deposition of H3K9me. responsible for mono-, di-, and tri-methylation of histone H3K9 However, the process involving the coupling of the “read” and “write” (H3K9me1/2/3) (6, 21).
    [Show full text]